ClinicalTrials.gov
public full text
Public Domain
Flurbiprofen Axetil for Uterine Contraction Pain
Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress the uterine contraction pain after abortion effectively.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pain Control In First Trimester Medical Abortion: A Randomized Trial#1197628
- 4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions#803573
- Methadone and Medication Abortion#1338052
- Analgesia for 2nd Trimester Termination of Pregnancy#849907
- Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.#813526
Record · ID 1231584
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive